Insider Trading activities of Catabasis Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Catabasis Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Catabasis Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Catabasis Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is CATB. The reporting company's CIK number is 1454789.
The total value of stock buying since 2005 is $22,201,608.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Catabasis Pharmaceuticals Inc (CATB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-06 1,850,134 $22,201,608 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Catabasis Pharmaceuticals Inc insiders (CATB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-06-30 Laufer Ron (Director) Buy 223,439 12.00 2,681,268
2015-06-30 Sv Life Sciences Fund V Strategic Partners, L.p. (10% Owner) Buy 391,090 12.00 4,693,080
2015-06-30 Clarus Ventures Ii, Llc (10% Owner) Buy 376,695 12.00 4,520,340
2015-06-30 Medimmune Ventures, Inc. (10% Owner) Buy 223,439 12.00 2,681,268
2015-06-30 George Jean (Director) Buy 258,776 12.00 3,105,312
2015-06-30 Galakatos Nicholas (Director) Buy 376,695 12.00 4,520,340

Insider trading activities including stock purchases, stock sales, and option exercises of CATB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Catabasis Pharmaceuticals Inc (symbol CATB, CIK number 1454789) see the Securities and Exchange Commission (SEC) website.